We are independent & ad-supported. We may earn a commission for purchases made through our links.
Advertiser Disclosure
Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.
How We Make Money
We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently of our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.
Conditions

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

What Is Adenocarcinoma in Situ?

By Erin J. Hill
Updated: Mar 03, 2024
Views: 15,627
Share

Adenocarcinoma in situ refers to pre-cancerous cells, usually found on the female cervix. They typically affect glandular cells and are a precursor for adenocarcinoma. This form of cervical cancer is more aggressive than others. When found while in situ, or only in its original location, it is much more easily treated. The condition is often discovered during a routine pap smear exam.

Patients with adenocarcinoma in situ may be given various treatment options. Pre-cancerous cells may be frozen or scraped off the surface of the cervix, although this is not always effective with this form of the disease. A partial or full hysterectomy may be required when cells seem to be spreading rapidly, as this could indicate a more aggressive form of the disease. Women of child-bearing age may be able to receive other treatments, although these are not always as effective and may allow cancerous cells the chance to regrow.

When adenocarcinoma in situ is in its earliest stages, aggressive therapy may not be needed. Each patient is diagnosed and treated individually. After treatment, frequent pap smear exams may be needed to rule out regrowth. Additional treatments may be necessary for those whose cancers have returned. Treatments may include chemotherapy, radiation therapy, and full hysterectomy if not performed upon diagnosis.

Many forms of adenocarcinoma in situ are caused by a particular strain of human papillomavirus (HPV). This is a sexually transmitted viral infection, similar to the strain which causes genital herpes. Most women who carry HPV have no symptoms, but it is a leading cause of cervical cancers. It can be prevented by practicing safe sex or by engaging in sexual activity with a monogamous, uninfected partner.

Cervical cancer, including adenocarcinoma in situ,can often be detected early through annual pap smears. This is an exam which involves inserting a small cotton swab into the cervix in order to collect a tissue sample. The tissue is examined and tested for cervical cancer and other abnormalities. Most women are advised to begin this exams yearly upon turning 18 years of age, or as soon as they become sexually active. Once a woman has gotten three consecutive normal pap smear results, she may be able to begin testing once every three years rather than annually.

Share
The Health Board is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.
Discussion Comments
Share
https://www.thehealthboard.com/what-is-adenocarcinoma-in-situ.htm
Copy this link
The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.

The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.